CBLL — CeriBell, Inc. stock price, charts and financials

QT37CeriBell, Inc.

CeriBell, Inc. (NASDAQ: CBLL) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.52
+0.21+1.15%
OverviewShort InterestFilings
CBLLQT37CeriBell, Inc.·NASDAQ
18.52+1.15%
News
Up 1.1% — CeriBell Says U.S. CMS Grants New Technology Add-On Payment For Up To $2,171 Per Eligible Medicare Patient Case Utilizing Ceribell Delirium Monitor System (Benzinga).
Medium confidence
TA
Loading chart...
Screen all →
TCMD+1.21%$30.14BBNX+9.14%$14.57SSII-3.04%$3.83BWAY-0.06%$15.80SIBN-0.05%$18.44INMD+0.13%$15.37CTKB-0.70%$4.28BVS-0.37%$13.42
Snapshot
Index-P/E-EPS (ttm)-1.63Insider Own16.23%Shs Outstand37.94MPerf Week3.87%
Market Cap702.70MForward P/E-EPS next Y-1.15Insider Trans-7.03%Shs Float24.72MPerf Month-6.42%
Enterprise Value582.70MPEG-EPS next Q-Inst Own-Short Float7.47%Perf Quarter-8.63%
Income-61.00MP/S7.40EPS this Y-4.72%Inst Trans-Short Ratio5.57Perf Half Y-8.41%
Sales95.00MP/B4.98EPS next Y32.82%ROA-33.90%Short Interest1.85MPerf YTD-15.55%
Book/sh3.72P/C4.98EPS next 5Y-ROE-38.19%52W High24.33 -23.88%Perf Year30.98%
Cash/sh3.72P/FCF-EPS past 3/5Y-ROIC-39.83%52W Low10.85 70.69%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y50.71% -Gross Margin87.72%Volatility3.60% 4.12%Perf 5Y-
Dividend TTM-EV/Sales6.13EPS Y/Y TTM51.92%Oper. Margin-68.31%ATR (14)0.82Perf 10Y-
Dividend Ex-Date-Quick Ratio9.87Sales Y/Y TTM46.15%Profit Margin-63.51%RSI (14)52.03Recom2.00
Dividend Gr. 3/5Y-Current Ratio10.30EPS Q/Q-44.44%SMA201.01%Beta1.31Target Price25.00
Payout0.00%Debt/Eq0.14Sales Q/Q30.00%SMA50-0.03%Rel Volume0.89Prev Close18.31
Employees327LT Debt/Eq0.14EarningsAug 10SMA200-0.09%Avg Volume365.37KPrice18.52
IPO DateOct 11, 2024Option/ShortYes / YesEPS/Sales Surpr.-33.07% 1.57%Net Debt/EBITDA0.40Volume326,808Change1.15%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26ReiteratedCanaccord GenuityBuy$30 → $25
Dec-15-25ReiteratedBTIGBuy$30
Nov-05-24ReiteratedCanaccord Genuity$30
Latest News
Company

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue9589654526
Cost of Goods Sold Incl. D&A1211974
Gross Profit8478573821
Selling, General and Administrative Excl. Other128118835950
Research and Development21191497
Other Operating Expense00-101
Operating Income-66-58-40-30-36
Interest Expense02222
Unusual Expense
—————
Non-Operating Income (Expense)77130
Net Income Before Taxes-61-53-40-29-37
Income Taxes
00000
Consolidated Net Income-61-53-40-29-37
Net Income From Continuing Operations-61-53-40-29-37
Net Income-61-53-40-29-37
EPS (Recurring)-1.63-1.46-3.39-1.26-1.59
EPS (Basic, Before Extraordinaries)-1.63-1.46-3.39-1.26-1.59
EPS (Diluted)-1.63-1.46-3.39-1.26-1.59
EBITDA-58-50-37-27-35
Other After Tax Adjustments
—————
Stock Option Compensation Expense
—————
Price To Earnings Ratio
—————
Price To Sales Ratio7.419.124.78——
Gross Margin88.4287.6487.6984.4480.77
Operating Margin-69.47-65.17-61.54-66.67-138.46
Net Margin-64.21-59.55-61.54-64.44-142.31
Shares Outstanding3837122323
Market Capitalization704811311——
Operating Lease Expense
—————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$25.31$21.24$17.18$13.11$9.04● Close Price0.00M1.16M2.32M3.49M4.65MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Chao XingjuanPresident and CEOJul 07 '26Sale19.9023,554468,725802,317Jul 09
Chao XingjuanPresident and CEOJul 07 '26Option Exercise4.7025,000117,500825,871Jul 09
BURKE WILLIAM WDirectorJun 30 '26Sale19.842,20743,78723,022Jul 02
TPG GP A, LLCother: Former 10% OwnerJun 26 '26Sale20.12202,3684,071,7053,765,054Jun 30
Taylor Joseph MichaelDirectorJun 11 '26Sale18.415,500101,25561,573Jun 15
Chao XingjuanPresident and CEOJun 08 '26Option Exercise4.7025,000117,500839,871Jun 10
Chao XingjuanPresident and CEOJun 08 '26Sale18.3323,554431,745816,317Jun 10
Foehr DavidSenior VP, Finance and PAOMay 22 '26Sale18.8086216,20637,751May 26
Blumberg ScottChief Financial OfficerMay 21 '26Sale18.001,38724,966147,683May 26
Manni Joseph S.Chief Revenue OfficerMay 21 '26Sale18.001,37824,80456,291May 26
Foehr DavidSenior VP, Finance and PAOMay 21 '26Sale18.0098717,76638,613May 26
Woo RaymondChief Technology OfficerMay 21 '26Sale18.001,96635,388195,682May 26
Chao XingjuanPresident and CEOMay 21 '26Sale18.006,030108,540830,317May 26
Chao XingjuanPresident and CEOMay 05 '26Option Exercise4.7025,000117,500859,901May 07
Chao XingjuanPresident and CEOMay 05 '26Sale20.0925,000502,294836,347May 07
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.